Nevro (NVRO) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

NVRO Stock Forecast

Nevro stock forecast is as follows: an average price target of $32.72 (represents a 650.46% upside from NVRO’s last price of $4.36) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.

NVRO Price Target

The average price target for Nevro (NVRO) is $32.72 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $125.00 to $5.00. This represents a potential 650.46% upside from NVRO's last price of $4.36.

NVRO Analyst Ratings

Hold

According to 18 Wall Street analysts, Nevro's rating consensus is 'Hold'. The analyst rating breakdown for NVRO stock is 0 'Strong Buy' (0.00%), 7 'Buy' (38.89%), 9 'Hold' (50.00%), 2 'Sell' (11.11%), and 0 'Strong Sell' (0.00%).

Nevro Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 15, 2024	David Rescott	Robert W. Baird	$5.00	$4.92	1.63%	14.68%
Aug 08, 2024	Joanna Wuensch	Citigroup	$6.89	$5.67	21.52%	58.03%
Aug 08, 2024	Richard Newitter	Truist Financial	$5.50	$5.08	8.27%	26.15%
Aug 07, 2024	David Rescott	Robert W. Baird	$8.00	$5.00	60.00%	83.49%
Aug 07, 2024	Matthew Taylor	Jefferies	$7.00	$4.83	44.93%	60.55%
Aug 07, 2024	Adam Maeder	Piper Sandler	$7.00	$8.69	-19.45%	60.55%
Aug 07, 2024	Nathan Treybeck	Wells Fargo	$5.50	$8.69	-36.71%	26.15%
Apr 11, 2024	Anthony Petrone	Mizuho Securities	$16.00	$13.28	20.48%	266.97%
Apr 08, 2024	Nathan Treybeck	Wells Fargo	$14.00	$13.29	5.34%	221.10%
Jun 06, 2023	Suraj Kalia	Oppenheimer	$40.00	$23.71	68.72%	817.43%

Row per page

Go to

The latest Nevro stock forecast, released on Oct 15, 2024 by David Rescott from Robert W. Baird, set a price target of $5.00, which represents a 1.63% increase from the stock price at the time of the forecast ($4.92), and a 14.68% increase from NVRO last price ($4.36).

Nevro Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	9
Avg Price Target	-	$5.00	$8.32
Last Closing Price	$4.36	$4.36	$4.36
Upside/Downside	-100.00%	14.68%	90.83%

In the current month, the average price target of Nevro stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nevro's last price of $4.36. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 08, 2024	Citigroup	Sell	Neutral	Upgrade
Aug 08, 2024	Wolfe Research	-	Peer Perform	Upgrade
Aug 07, 2024	Jefferies	Underperform	Underperform	Hold
Aug 07, 2024	Piper Sandler	Underweight	Underweight	Hold
Aug 07, 2024	Wells Fargo	Equal-Weight	Underweight	Downgrade
Aug 07, 2024	JMP Securities	Perform	Market Perform	Downgrade
Aug 07, 2024	JMP Securities	-	Perform	Downgrade
Jul 10, 2024	Citigroup	Sell	Sell	Hold
May 22, 2024	Citigroup	Neutral	Sell	Downgrade
Apr 03, 2024	Citigroup	Neutral	Neutral	Hold

Row per page

Go to

Nevro's last stock rating was published by Citigroup on Aug 08, 2024. The company Upgrade its NVRO rating from "Sell" to "Neutral".

Nevro Financial Forecast

Nevro Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$103.86M	$108.81M	$96.33M	$113.84M	$100.47M	$104.21M	$87.84M	$102.76M	$93.20M	$102.33M	$88.61M	$109.73M	$108.46M	$56.39M	$87.47M	$114.37M	$100.16M
Avg Forecast	$112.30M	$102.37M	$108.13M	$99.77M	$109.90M	$100.57M	$103.40M	$94.34M	$100.12M	$93.09M	$107.11M	$97.90M	$112.26M	$95.87M	$108.19M	$95.08M	$113.42M	$99.22M	$104.34M	$86.19M	$100.26M	$91.59M	$102.32M	$85.26M	$107.92M	$104.00M	$37.86M	$88.06M	$111.80M	$92.27M
High Forecast	$118.26M	$107.80M	$113.87M	$105.06M	$115.73M	$105.90M	$108.89M	$101.79M	$101.52M	$93.57M	$107.11M	$97.90M	$112.33M	$104.57M	$113.93M	$100.12M	$119.44M	$99.22M	$104.34M	$86.19M	$100.26M	$91.59M	$102.32M	$85.26M	$107.92M	$104.00M	$37.86M	$88.06M	$111.80M	$92.27M
Low Forecast	$108.08M	$98.52M	$104.07M	$96.02M	$105.77M	$96.79M	$99.52M	$88.65M	$99.11M	$92.60M	$107.11M	$97.90M	$112.05M	$94.58M	$104.12M	$91.51M	$109.16M	$99.22M	$104.34M	$86.19M	$100.26M	$91.59M	$102.32M	$85.26M	$107.92M	$104.00M	$37.86M	$88.06M	$111.80M	$92.27M
# Analysts	3	3	4	5	4	5	2	7	10	9	2	2	4	15	9	9	13	13	13	13	7	7	7	7	9	4	5	4	4	3
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.08%	1.01%	1.01%	1.00%	1.01%	1.00%	1.02%	1.02%	1.02%	1.00%	1.04%	1.02%	1.04%	1.49%	0.99%	1.02%	1.09%

Nevro's average Quarter revenue forecast for Dec 23 based on 4 analysts is $112.26M, with a low forecast of $112.05M, and a high forecast of $112.33M. NVRO's average Quarter revenue forecast represents a 8.09% increase compared to the company's last Quarter revenue of $103.86M (Sep 23).

Nevro EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	4	5	4	5	2	7	10	9	2	2	4	15	9	9	13	13	13	13	7	7	7	7	9	4	5	4	4	3
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-25.56M	$-25.64M	$-36.32M	$-19.36M	$-18.75M	$-20.55M	$-30.04M	$-24.00M	$-44.13M	$-13.59M	$-20.68M	$1.69M	$-1.39M	$-32.87M	$-19.63M	$-8.41M	$-12.76M
Avg Forecast	$-16.96M	$-15.46M	$-16.33M	$-15.06M	$-16.59M	$-15.18M	$-15.61M	$-14.24M	$-15.12M	$-14.05M	$-16.17M	$-40.31M	$-16.95M	$-14.47M	$-16.33M	$-36.65M	$-26.40M	$-26.04M	$-27.38M	$-33.31M	$-26.31M	$-24.04M	$-26.85M	$-20.44M	$-28.32M	$-27.29M	$-9.93M	$-23.80M	$-29.34M	$-24.22M
High Forecast	$-16.32M	$-14.87M	$-15.71M	$-14.50M	$-15.97M	$-14.61M	$-15.02M	$-13.38M	$-14.96M	$-13.98M	$-16.17M	$-32.25M	$-16.92M	$-14.28M	$-15.72M	$-29.32M	$-21.12M	$-26.04M	$-27.38M	$-26.65M	$-26.31M	$-24.04M	$-26.85M	$-16.35M	$-28.32M	$-27.29M	$-9.93M	$-19.04M	$-29.34M	$-24.22M
Low Forecast	$-17.85M	$-16.28M	$-17.19M	$-15.86M	$-17.47M	$-15.99M	$-16.44M	$-15.37M	$-15.33M	$-14.13M	$-16.17M	$-48.37M	$-16.96M	$-15.79M	$-17.20M	$-43.98M	$-31.68M	$-26.04M	$-27.38M	$-39.98M	$-26.31M	$-24.04M	$-26.85M	$-24.53M	$-28.32M	$-27.29M	$-9.93M	$-28.56M	$-29.34M	$-24.22M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.77%	1.57%	0.99%	0.73%	0.72%	0.75%	0.90%	0.91%	1.84%	0.51%	1.01%	-0.06%	0.05%	3.31%	0.83%	0.29%	0.53%

7 analysts predict NVRO's average Quarter EBITDA for Mar 21 to be $-20.44M, with a high of $-16.35M and a low of $-24.53M. This is -1311.54% lower than Nevro's previous annual EBITDA (Dec 20) of $1.69M.

Nevro Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	4	5	4	5	2	7	10	9	2	2	4	15	9	9	13	13	13	13	7	7	7	7	9	4	5	4	4	3
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-23.48M	$-24.72M	$-35.03M	$-19.19M	$81.51M	$-24.99M	$-34.33M	$-30.13M	$-50.08M	$-21.59M	$-29.56M	$-7.13M	$-9.98M	$-41.06M	$-24.89M	$-13.74M	$-17.85M
Avg Forecast	$-19.28M	$-23.14M	$-21.90M	$-26.50M	$-19.62M	$-19.37M	$-21.16M	$-31.58M	$-29.12M	$-30.40M	$-26.03M	$-46.06M	$-18.26M	$-28.70M	$-25.75M	$-41.88M	$-33.15M	$-8.29M	$-29.85M	$-38.07M	$-31.65M	$-32.21M	$-27.08M	$-29.21M	$-12.33M	$-21.70M	$-60.08M	$-30.17M	$-23.38M	$-31.41M
High Forecast	$-18.34M	$-22.01M	$-20.83M	$-25.21M	$-18.66M	$-18.42M	$-20.13M	$-21.29M	$-21.08M	$-28.92M	$-24.75M	$-36.85M	$-15.34M	$-16.40M	$-24.49M	$-33.50M	$-26.52M	$-8.29M	$-29.85M	$-30.46M	$-31.65M	$-32.21M	$-27.08M	$-23.37M	$-12.33M	$-21.70M	$-60.08M	$-24.13M	$-23.38M	$-31.41M
Low Forecast	$-20.61M	$-24.74M	$-23.41M	$-28.33M	$-20.97M	$-20.70M	$-22.62M	$-35.83M	$-36.41M	$-32.50M	$-27.82M	$-55.28M	$-21.19M	$-33.92M	$-27.53M	$-50.25M	$-39.78M	$-8.29M	$-29.85M	$-45.68M	$-31.65M	$-32.21M	$-27.08M	$-35.05M	$-12.33M	$-21.70M	$-60.08M	$-36.20M	$-23.38M	$-31.41M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.82%	0.96%	0.84%	0.58%	-9.84%	0.84%	0.90%	0.95%	1.55%	0.80%	1.01%	0.58%	0.46%	0.68%	0.83%	0.59%	0.57%

Nevro's average Quarter net income forecast for Dec 22 is $-33.15M, with a range of $-39.78M to $-26.52M. NVRO's average Quarter net income forecast represents a -140.67% decrease compared to the company's last Quarter net income of $81.51M (Sep 22).

Nevro SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	4	5	4	5	2	7	10	9	2	2	4	15	9	9	13	13	13	13	7	7	7	7	9	4	5	4	4	3
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$81.15M	$86.76M	$86.19M	$80.65M	$78.19M	$83.97M	$79.33M	$82.64M	$79.52M	$73.88M	$73.27M	$67.07M	$68.51M	$60.17M	$71.40M	$76.01M	$72.91M
Avg Forecast	$87.61M	$79.86M	$84.36M	$77.84M	$85.74M	$78.46M	$80.67M	$73.60M	$78.11M	$72.62M	$83.57M	$76.38M	$87.59M	$74.79M	$84.41M	$74.18M	$90.90M	$76.88M	$80.85M	$66.78M	$77.69M	$70.97M	$79.29M	$72.40M	$83.63M	$80.59M	$29.33M	$86.55M	$86.63M	$71.50M
High Forecast	$92.26M	$84.10M	$88.84M	$81.97M	$90.29M	$82.62M	$84.95M	$79.41M	$79.20M	$73.00M	$83.57M	$76.38M	$87.64M	$81.59M	$88.88M	$78.11M	$109.08M	$76.88M	$80.85M	$66.78M	$77.69M	$70.97M	$79.29M	$86.88M	$83.63M	$80.59M	$29.33M	$103.86M	$86.63M	$71.50M
Low Forecast	$84.32M	$76.86M	$81.19M	$74.91M	$82.52M	$75.51M	$77.64M	$69.17M	$77.32M	$72.25M	$83.57M	$76.38M	$87.42M	$73.79M	$81.23M	$71.39M	$72.72M	$76.88M	$80.85M	$66.78M	$77.69M	$70.97M	$79.29M	$57.92M	$83.63M	$80.59M	$29.33M	$69.24M	$86.63M	$71.50M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.08%	1.03%	1.16%	0.89%	1.02%	1.04%	1.19%	1.06%	1.12%	0.93%	1.01%	0.80%	0.85%	2.05%	0.83%	0.88%	1.02%

Nevro's average Quarter SG&A projection for Dec 23 is $87.59M, based on 4 Wall Street analysts, with a range of $87.42M to $87.64M. The forecast indicates a 7.93% rise compared to NVRO last annual SG&A of $81.15M (Sep 23).

Nevro EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	3	3	4	5	4	5	2	7	10	9	2	2	4	15	9	9	13	13	13	13	7	7	7	7	9	4	5	4	4	3
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.65	$-0.69	$-0.98	$-0.54	$2.30	$-0.71	$-0.98	$-0.86	$-1.44	$-0.62	$-0.85	$-0.21	$-0.29	$-1.21	$-0.78	$-0.44	$-0.58
Avg Forecast	$-0.52	$-0.62	$-0.59	$-0.71	$-0.53	$-0.52	$-0.57	$-0.85	$-0.78	$-0.81	$-0.70	$-1.05	$-0.49	$-0.77	$-0.69	$-1.05	$-0.49	$-0.22	$-0.81	$-1.10	$-0.86	$-0.87	$-0.73	$-0.85	$-0.33	$-0.59	$-1.63	$-0.99	$-0.63	$-0.85
High Forecast	$-0.49	$-0.59	$-0.56	$-0.68	$-0.50	$-0.49	$-0.54	$-0.57	$-0.56	$-0.77	$-0.66	$-1.00	$-0.41	$-0.44	$-0.66	$-1.00	$-0.46	$-0.22	$-0.81	$-1.10	$-0.86	$-0.87	$-0.73	$-0.85	$-0.33	$-0.59	$-1.63	$-0.99	$-0.63	$-0.85
Low Forecast	$-0.55	$-0.66	$-0.63	$-0.76	$-0.56	$-0.55	$-0.61	$-0.96	$-0.98	$-0.87	$-0.75	$-1.13	$-0.57	$-0.91	$-0.74	$-1.12	$-0.52	$-0.22	$-0.81	$-1.10	$-0.86	$-0.87	$-0.73	$-0.85	$-0.33	$-0.59	$-1.63	$-0.99	$-0.63	$-0.85
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.85%	1.00%	0.93%	1.11%	-10.25%	0.88%	0.89%	1.00%	1.65%	0.85%	1.00%	0.63%	0.49%	0.74%	0.79%	0.70%	0.68%

According to 13 Wall Street analysts, Nevro's projected average Quarter EPS for Dec 22 is $-0.49, with a low estimate of $-0.52 and a high estimate of $-0.46. This represents a -121.20% decrease compared to NVRO previous annual EPS of $2.30 (Sep 22).

Nevro Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
NVRO	Nevro	$4.36	$32.72	650.46%	Hold
SGHT	Sight Sciences	$3.76	$9.00	139.36%	Hold
LUNG	Pulmonx	$6.42	$11.93	85.83%	Buy
RXST	RxSight	$45.05	$70.11	55.63%	Buy
KIDS	OrthoPediatrics	$26.47	$39.60	49.60%	Buy
NPCE	NeuroPace	$9.00	$12.88	43.11%	Buy
LIVN	LivaNova	$51.70	$70.50	36.36%	Buy
CNMD	CONMED	$71.71	$96.00	33.87%	Buy
OFIX	Orthofix Medical	$18.68	$24.00	28.48%	-
IRMD	IRadimed	$53.23	$60.00	12.72%	Buy
CVRX	CVRx	$14.77	$16.33	10.56%	Buy
FNA	Paragon 28	$10.43	$11.50	10.26%	Buy
ITGR	Integer	$135.88	$138.00	1.56%	Buy
SRDX	Surmodics	$39.19	$39.50	0.79%	Buy
GKOS	Glaukos	$140.83	$123.44	-12.35%	Buy

NVRO Forecast FAQ

Is Nevro a good buy?

No, according to 18 Wall Street analysts, Nevro (NVRO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 38.89% of NVRO's total ratings.

What is NVRO's price target?

Nevro (NVRO) average price target is $32.72 with a range of $5 to $125, implying a 650.46% from its last price of $4.36. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Nevro stock go up soon?

According to Wall Street analysts' prediction for NVRO stock, the company can go up by 650.46% (from the last price of $4.36 to the average price target of $32.72), up by 2766.97% based on the highest stock price target, and up by 14.68% based on the lowest stock price target.

Can Nevro stock reach $7?

NVRO's average twelve months analyst stock price target of $32.72 supports the claim that Nevro can reach $7 in the near future.

What are Nevro's analysts' financial forecasts?

Nevro's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $408.2M (high $432.3M, low $390.72M), average EBITDA is $-61.63M (high $-58.991M, low $-65.269M), average net income is $-91.724M (high $-78.497M, low $-100M), average SG&A $318.47M (high $337.27M, low $304.84M), and average EPS is $-2.457 (high $-2.103, low $-2.683). NVRO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $422.57M (high $444.98M, low $406.69M), average EBITDA is $-63.799M (high $-61.401M, low $-67.183M), average net income is $-90.824M (high $-86.387M, low $-97.088M), average SG&A $329.68M (high $347.17M, low $317.29M), and average EPS is $-2.433 (high $-2.314, low $-2.601).

Did the NVRO's actual financial results beat the analysts' financial forecasts?

Based on Nevro's last annual report (Dec 2022), the company's revenue was $406.36M, beating the average analysts forecast of $403.17M by 0.79%. Apple's EBITDA was $-204M, beating the average prediction of $-113M by 80.17%. The company's net income was $3M, missing the average estimation of $-109M by -102.74%. Apple's SG&A was $322.14M, beating the average forecast of $315.42M by 2.13%. Lastly, the company's EPS was $0.08, missing the average prediction of $-2.621 by -103.05%. In terms of the last quarterly report (Sep 2023), Nevro's revenue was $103.86M, beating the average analysts' forecast of $95.87M by 8.34%. The company's EBITDA was $-25.559M, beating the average prediction of $-14.474M by 76.58%. Nevro's net income was $-23.479M, missing the average estimation of $-28.698M by -18.19%. The company's SG&A was $81.15M, beating the average forecast of $74.79M by 8.50%. Lastly, the company's EPS was $-0.65, missing the average prediction of $-0.769 by -15.46%